Pegcetacoplan-How to deal with side effects of Empaveli

Pegcetacoplan (Pegcetacoplan), as a C3 complement inhibitor, has gradually been included in international guidelines as a core option in the treatment of complement-related diseases such as PNH. Because its target is located in the upstream of the complement cascade, it is outstanding in inhibiting red blood cell destruction, but it may also cause typical adverse events related to complement inhibition. Overseas data shows that the most important things that patients need to pay attention to when using Empaveli are infection risks, injection site reactions, gastrointestinal discomfort, and fluctuating reactions related to hemolysis. Therefore, reasonable monitoring and management strategies are particularly critical.

At the core of safety management, the risk of infection is always a concern with C3 inhibitors. Because the complement system plays a key role in defending against specific enveloped bacteria, international experts generally recommend completing necessary vaccinations before using Empaveli and continuing to pay attention to fever, chills, headache and other early signs that may indicate infection during treatment. Once signs of suspected infection appear, you should seek medical treatment promptly and perform anti-infective treatment under professional guidance to reduce the possibility of serious complications.

Injection site reactions are another common complaint and include localized redness, swelling, itching, or mild pain. In most cases, these reactions are transient and can be alleviated by applying cold compresses, local care, or changing the injection site. If reactions recur, a physician can evaluate the need to adjust injection frequency or dosing technique and ensure that the patient masters a standardized subcutaneous injection method.

Some patients may experience mild gastrointestinal discomfort, such as nausea, loss of appetite, or transient abdominal pain at the beginning of treatment, which is usually related to the body's adaptation process to the drug. Staying well hydrated, eating small meals more frequently, or briefly adjusting the time of administration can help relieve symptoms. If gastrointestinal discomfort affects daily life, feedback should be reported to the doctor, who will determine whether the treatment plan needs to be fine-tuned.

Reference materials:https://empaveli.com/